Christine Martin DPhil Christine Martin DPhil Head of Ventures

As Head of Ventures, Christine oversees our investment activities, with the team investing over £5 million each year in young companies.

With expertise in Life Science investment, Christine has a focus on drug discovery with a broad portfolio of technologies, including University of Cambridge spin-outs Carrick, STORM, Z-factor, PhoreMost, Qkine, and PolyProX. Christine was featured in BioBeat’s 50 Movers and Shakers in BioBusiness 2018.

Previously, Christine worked for six years in the Life Sciences Tech Transfer team managing licensing of University IP. Christine also managed the University of Cambridge-GSK open innovation drug discovery initiative based at the SBC, working closely with academics to gain funding to develop translational projects.

Prior to that, she enjoyed 11 years working for Biotica, a biotechnology spin-out from the University of Cambridge as Department Director and Project Leader.

Christine has an MA and DPhil from the University of Oxford. She is the author of over 20 peer reviewed journal articles and over 20 patents. She was also the recipient of the Arthur E. Schwarting award for the best article published in the Journal of Natural Products in 2006.

Christine joined Cambridge Enterprise in September 2011.